Aromatase Inhibitors Combined with Growth Hormone: A Cost-effective Last Chance for Improving Boysâ Stature at the Near-End of Growth?
Journal Title: Journal of Clinical and Molecular Endocrinology - Year 2017, Vol 2, Issue 1
Abstract
Two studies have recently shown a clear benefit of using nonsteroidal aromatase inhibitors (AIs) in combination with growth hormone (rhGH) in pubertal boys of very short stature (between -2.5 and - 3 SDS) who are approaching the end of their growth [1,2]. AIs have been used in human therapeutics since the 1990s, mostly in adults [3], to block aromatase by binding to the heme iron of aromatase, a cytochrome p450 enzyme that catalyzes the formation of C18 estrogens (estrone and estradiol) from C19 androgens (androstenedione and testosterone) [4]. In males, circulating estradiol is derived from direct testicular secretion (20%) and from peripheral conversion of adrenal or testicular androgens [5,6].
Authors and Affiliations
Pierre Bougnères
Keywords
Related Articles
- EP ID EP305624
- DOI 10.21767/2572-5432.100036
- Views 49
- Downloads 0
A Descriptive Study on Children with Congenital Adrenal Hyperplasia Attending Assiut University Children Hospital
Introduction: Congenital adrenal hyperplasia is a group of autosomal recessive disorders that result from the deficiency of one of several enzymes involved in the steroidogenic pathway for cortisol biosynthesis. The most...
Ketotifen and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
Objective: Mast cells found to be an important contributor to inflammation, obesity, diabetes and atherosclerosis. We evaluate the ability of ketotifen to reduce cardiovascular risk in patient with type 2 diabetes millet...
The Other Legacy of Antonie Van Leeuwenhoek: The Polyamines
Antonie van Leeuwenhoek (1632-1723) left us two legacies; the first is the microscope and the second, the discovering of polyamines in the human semen.
Can Betatrophin be a New Biochemical Marker in the Diagnosis of Insulinoma?
Originating from the β cells of Langerhans islets, insulinoma has an incidence of 1 to 4 in one million in the general population, but is the most common tumor among pancreatic neuroendocrine tumors [1]. It can be life-t...
False Positive TSH Receptor Binding Inhibitory Immunoglobulin in a Patient with Overt Hyperthyroidism Caused by Painless Thyroiditis
The diagnosis of Graves’s disease (GD) can be challenging in patients with atypical presentations of hyperthyroidism. Recently, TSH receptor antibody assays are proposed as first-line test for suspected GD. I here report...